 |
||||||||||||||||||||||||||||||
|
 |
|||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
SAN ANTONIO, March 4, 2010—The Redes En Acción research team unveiled a new video at its recent 10th Annual National Steering Committee Meeting highlighting the cancer control and prevention activities of the initiative conducted by the National Network Center and its five regional sites (San Francisco, San Diego, Houston, Miami and New York) over the […]
You are cordially invited to join Dr. Paul Haluska in a teleconference for an update on and to discuss your questions/comments about the North Central Cancer Treatment Group Trial N0733 for HER2 positive breast cancer patients who have had their cancer back or grow through first line treatment with Herceptin. In this trial, we […]
News from the ASCO GU Symposium, February 24, 2009
* The development of a personalized risk assessment tool that combines prostate-specific antigen (PSA) test results with additional prostate cancer risk factors to more accurately predict a man’s future risk of developing prostate cancer, compared with PSA test results alone
* A study finding that a novel molecular […]
Studies highlighted in ASCO press release from the GI Symposium in January
* An economic analysis showing that routine testing for KRAS gene mutations in patients with metastatic colorectal cancer could save the U.S. health system up to $604 million per year in the cost of the drug cetuximab (Erbitux). Recent studies have shown that cetuximab […]
Green tea products have become regarded as a valuable health supplement, as studies have shown evidence of its benefit against a variety of diseases, including cancer. However, a new study suggests that some components of green tea may counteract the anticancer effects of one cancer therapy, bortezomib (Velcade®), and may be contraindicated for patients taking […]
Waiting for results of a breast biopsy appears to affect stress hormone levels just as much as finding out you have cancer, a new study shows. Harvard researchers tracked 126 women who were undergoing breast biopsy, monitoring their levels of the stress hormone cortisol while they waited. For the full story go to http://www.nytimes.com/2009/02/25/health/25stress.html?ref=research#
From the […]
|
Mission Statement |
 |
Blog |
|
News |
|
Programs and Services |
|
Founders |
|
Join the Network |
|
Contact Us |
|
|
